Royal Bank of Canada
DGX icon

Royal Bank of Canada’s Quest Diagnostics DGX Stock Holding History

Royal Bank of Canada’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-50,000
Closed -$4.01M – 6673
2020
Q1 		$4.01M Hold
50,000
– – ﹤0.01% 1966
2019
Q4 		$5.34M Buy
+50,000
New +$5.21M ﹤0.01% 2113

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Royal Bank of Canada's DGX Position: Q1 2026 in Review

Royal Bank of Canada reduced its Quest Diagnostics (DGX) stake by 13% in Q1 2026, selling an estimated $5.87M and leaving 198,534 shares worth $38.9M. The position accounts for 0.01% of the portfolio, ranked #1046.

Royal Bank of Canada first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $160M in Q2 2025. 1,066 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Royal Bank of Canada held 198,534 shares of Quest Diagnostics worth $38.9M as of Q1 2026.
  • Royal Bank of Canada sold 30,197 Quest Diagnostics shares in Q1 2026, an estimated $5.87M.
  • Quest Diagnostics made up 0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #1046 holding.
  • Royal Bank of Canada first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Quest Diagnostics position peaked at $160M in Q2 2025.
  • 1,066 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.